Compounds > indobufen
Page last updated: 2024-08-26

indobufen and warfarin

indobufen has been researched along with warfarin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's3 (30.00)29.6817
2010's2 (20.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Coccheri, S; Morocutti, C1
Amabile, G; Fattapposta, F; Heiman, F; Lavezzari, M; Matteoli, S; Morocutti, C; Trappolini, M1
Amabile, G; Cataldo, G; Coccheri, S; Fattapposta, F; Lavezzari, M; Matteoli, S; Milanesi, G; Morocutti, C; Nicolosi, A; Pamparana, F; Trappolini, M1
Cohen, H; Ebrahim, S; Taylor, FC1
Prisco, D1
Pengo, V1
Gong, J; He, Q; Jin, J; Li, Y; Lou, X; Zhao, L1
Chen, HY; Gao, XY; He, Q; Jin, J; Li, H; Li, YW; Lin, B; Liu, YM; Qu, K; Wang, H; Xiong, XL; Yu, XY; Zheng, DN1

Reviews

2 review(s) available for indobufen and warfarin

ArticleYear
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation.
    BMJ (Clinical research ed.), 2001, Feb-10, Volume: 322, Issue:7282

    Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Hemorrhage; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Warfarin

2001
[Thromboembolism in non-rheumatic atrial fibrillation].
    Haematologica, 2001, Volume: 86, Issue:9 Suppl

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Consensus Development Conferences as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electric Countershock; Female; Hemorrhage; Humans; Incidence; International Normalized Ratio; Isoenzymes; Isoindoles; Male; Membrane Proteins; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Treatment Outcome; Warfarin

2001

Trials

5 trial(s) available for indobufen and warfarin

ArticleYear
[Embolic complications in atrial fibrillation. Data of the Studio Italiano Fibrillation Atriale (SIFA)].
    Il Giornale di chirurgia, 1995, Volume: 16, Issue:3

    Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Embolism; Female; Follow-Up Studies; Humans; Isoindoles; Italy; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Warfarin

1995
Aspirin and prevention of stroke.
    Lancet (London, England), 1994, Jan-22, Volume: 343, Issue:8891

    Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Warfarin

1994
[Italian Study on Atrial Fibrillation (SIFA): status report].
    Cardiologia (Rome, Italy), 1993, Volume: 38, Issue:12 Suppl 1

    Topics: Adult; Aged; Atrial Fibrillation; Cerebrovascular Disorders; Female; Humans; Isoindoles; Italy; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Warfarin

1993
Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.
    Stroke, 1997, Volume: 28, Issue:5

    Topics: Adult; Aged; Anticoagulants; Atrial Fibrillation; Cyclooxygenase Inhibitors; Female; Follow-Up Studies; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Prospective Studies; Treatment Outcome; Vascular Diseases; Warfarin

1997
Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial.
    Renal failure, 2023, Volume: 45, Issue:1

    Topics: Adult; Anticoagulants; Atrial Fibrillation; Fibrinolytic Agents; Hemorrhage; Humans; Nephrotic Syndrome; Thromboembolism; Treatment Outcome; Warfarin

2023

Other Studies

3 other study(ies) available for indobufen and warfarin

ArticleYear
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Haematologica, 2001, Volume: 86, Issue:9 Suppl

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Diabetes Complications; Double-Blind Method; Fibrinolytic Agents; Heart Valve Diseases; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Warfarin

2001
Comparison of the Effects of Indobufen and Warfarin in a Rat Model of Adenine-Induced Chronic Kidney Disease.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, May-14, Volume: 25

    Topics: Adenine; Animals; Anticoagulants; China; Disease Models, Animal; Fibrosis; Isoindoles; Kidney; Kidney Failure, Chronic; Male; Phenylbutyrates; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Warfarin

2019